Merck
CN

UHPLC Analysis of Sulfa Drugs on Ascentis® Express C18

UHPLC Analysis of Sulfa Drugs on Ascentis® Express C18 application for UHPLC

材料

分析色谱柱

产品编号
说明
价格

Ascentis® Express C18, 2 μm UHPLC 色谱柱

2 μm particle size, L × I.D. 10 cm × 2.1 mm

标准

产品编号
说明
价格

磺胺噻唑

磺胺嘧啶

99.0-101.0%

磺胺甲基嘧啶

VETRANAL®, analytical standard

CONDITIONS

column

Ascentis Express C18, 10 cm x 2.1 mm I.D., 2.0 μm particles (50813-U)

mobile phase

[A] 0.1% acetic acid; [B] 0.1% acetic acid in acetonitrile; (90:10, A:B)

flow rate

0.8 mL/min

pressure

10720 psi (739 bar)

column temp.

45 °C

detector

UV, 250 nm

injection

0.5 μL

sample

25 μg/mL in 90:10, water:methanol

说明

分析说明

The UHPLC method presented here shows the rapid analysis of the sulfa drugs sulfacetamide, sulfadiazine, sulfathiazole, and sulfamerazine on Ascentis Express 2 μm C18. Analysis time is less than one minute. The sulfa drugs analyzed here all contain a sulfanilamide substructure as active group.

法律信息

Ascentis is a registered trademark of Merck KGaA, Darmstadt, Germany